Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
2.860
-0.040 (-1.38%)
Nov 5, 2024, 3:48 PM EST - Market open

Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $23.23 million. The enterprise value is $45.48 million.

Market Cap 23.23M
Enterprise Value 45.48M

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024, before market open.

Earnings Date Nov 19, 2024
Ex-Dividend Date n/a

Share Statistics

Onconetix has 8.29 million shares outstanding. The number of shares has increased by 29.66% in one year.

Current Share Class 8.29M
Shares Outstanding 8.29M
Shares Change (YoY) +29.66%
Shares Change (QoQ) +0.22%
Owned by Insiders (%) 11.44%
Owned by Institutions (%) 1.12%
Float 3.49M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.00
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 31.07
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio 0.10
Quick Ratio 0.06
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.66

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -21.85%
Return on Capital (ROIC) -152.46%
Revenue Per Employee $121,979
Profits Per Employee -$4.43M
Employee Count 12
Asset Turnover 0.03
Inventory Turnover 3.45

Taxes

Income Tax -83,392
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.36% in the last 52 weeks. The beta is 3.73, so Onconetix's price volatility has been higher than the market average.

Beta (5Y) 3.73
52-Week Price Change -80.36%
50-Day Moving Average 4.67
200-Day Moving Average 5.95
Relative Strength Index (RSI) 32.43
Average Volume (20 Days) 56,787

Short Selling Information

The latest short interest is 20,287, so 0.24% of the outstanding shares have been sold short.

Short Interest 20,287
Short Previous Month 375,247
Short % of Shares Out 0.24%
Short % of Float 0.58%
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, Onconetix had revenue of $1.46 million and -$53.12 million in losses. Loss per share was -$104.97.

Revenue 1.46M
Gross Profit -837,449
Operating Income -15.60M
Pretax Income -45.82M
Net Income -53.12M
EBITDA -15.15M
EBIT -15.60M
Loss Per Share -$104.97
Full Income Statement

Balance Sheet

The company has $930,541 in cash and $15.28 million in debt, giving a net cash position of -$14.35 million or -$1.73 per share.

Cash & Cash Equivalents 930,541
Total Debt 15.28M
Net Cash -14.35M
Net Cash Per Share -$1.73
Equity (Book Value) -28.73M
Book Value Per Share -64.14
Working Capital -18.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.78 million and capital expenditures -$22,284, giving a free cash flow of -$15.81 million.

Operating Cash Flow -15.78M
Capital Expenditures -22,284
Free Cash Flow -15.81M
FCF Per Share -$1.91
Full Cash Flow Statement

Margins

Gross Margin -57.21%
Operating Margin -1,065.46%
Pretax Margin -3,634.95%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -1,900.76%

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.66%
Shareholder Yield -29.66%
Earnings Yield -220.84%
FCF Yield -65.71%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on September 24, 2024. It was a reverse split with a ratio of 0.025:1.

Last Split Date Sep 24, 2024
Split Type Reverse
Split Ratio 0.025:1

Scores

Onconetix has an Altman Z-Score of -3.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.1
Piotroski F-Score 2